A patient comes to your pharmacy and presents the following prescription. The prescription reads:
A patient comes to your pharmacy and presents the following prescription. The prescription reads:
A patient comes to your pharmacy and presents the following prescription. The prescription reads:
A patient comes to your pharmacy and presents the following prescription. The prescription reads:
Mr. Smith comes to the pharmacy and asks for the prescription drug Hydrochlorothiazide. Upon reviewing his profile, the pharmacist has found that the patient has no refills left on the current prescription. The pharmacist calls the prescriber but he is out of town for 3 days. The pharmacist gives 3 days worth of medication to Mr. Smith. Is the pharmacist acting in accordance with the standard of care?
Answer: Yes or No
Mr. Smith comes to the pharmacy and asks for the prescription drug Hydrochlorothiazide. Upon reviewing his profile, the pharmacist has found that the patient has no refills left on the current prescription. The pharmacist calls the prescriber but he is out of town for 3 days. The pharmacist gives 3 days worth of medication to Mr. Smith. Is the pharmacist acting in accordance with the standard of care?
Answer: Yes, [California Pharmacy Law Chapter 4000 Section 4064].
Hydrochlorothiazide is considered a maintenance drug. It is normally indicated for the treatment of blood pressure. Mr. Smith has been taking this drug to control his blood pressure.
The pharmacist tried to contact the physician to find the current status of therapy. The pharmacist made a reasonable effort to prevent any health consequences that may arise due to discontinuation of therapy. The pharmacist was in accordance with the standard of care.
Emergency Refill of Prescription without Prescriber Authorization:
(a). A prescription for a dangerous drug or dangerous device may be refilled without the prescriber's authorization if the prescriber is unavailable to authorize the refill and if, in the pharmacist's professional judgment, failure to refill the prescription might interrupt the patient's ongoing care and have a significant adverse effect on the patient's well-being.
(b). The pharmacist shall inform the patient that the prescription was refilled pursuant to this section.
(c). The pharmacist shall inform the prescriber within a reasonable period of time of any refills dispensed pursuant to this section.
(d). Prior to refilling a prescription pursuant to this section, the pharmacist shall make every reasonable effort to contact the prescriber. The pharmacist shall make an appropriate record, including the basis for proceeding under this section.
(e). The prescriber shall not incur any liability as the result of a refilling of a prescription pursuant to this section.
(f). Notwithstanding Section 4060 or any other law, a person may possess a dangerous drug or dangerous device furnished without prescription pursuant to this section.
A patient brings a new prescription that is electronically generated and contains an electronic signature of prescriber. What shall pharmacist do?
a. Fill the prescription.
b. Shall not fill the prescription.
Answer:
A patient brings a new prescription that is electronically generated and contains an electronic signature of prescriber. What shall pharmacist do?
a. Fill the prescription.
b. Shall not fill the prescription.
Answer: Shall not fill the prescription, [New York State Laws and Regulations Article 137, Section 6810 and http://www.op.nysed.gov/prof/pharm/pharmelectrans.htm question 5].
Once a prescription is handed to the patient it is no longer an electronic prescription and must contain the handwritten, pen-to-paper signature of the prescriber.
Which of the following drugs is classified as a controlled substance?
a. Cipro
b. Vibramycin
c. Lyrica
d. Antara
Answer:
Which of the following drugs is classified as a controlled substance?
a. Cipro
b. Vibramycin
c. Lyrica
d. Antara
Answer:(c) Lyrica (Pregabalin) is classified as a Schedule V controlled substance.It is indicated for:
1. Management of neuropathic pain associated with diabetic peripheral neuropathy
2. Management of postherpetic neuralgia
3. Adjunctive therapy for adult patients with partial onset seizures
4. Management of fibromyalgia
5. Management of neuropathic pain associated with spinal cord injury
If a paper copy prescription that is generated by the pharmacist or pharmacy technician from the electronic prescription system is printed, a manual signature of prescribing practitioner shall be obtained within 72 hours.
True or False
If a paper copy prescription that is generated by the pharmacist or pharmacy technician from the electronic prescription system is printed, a manual signature of prescribing practitioner shall be obtained within 72 hours.
Answer: False,[Title 12 Alaska Administrative Code (AAC) Section 52.490(a)(6)].
If a paper copy prescription that is generated by the pharmacist or pharmacy technician from the electronic prescription system is printed, an electronic signature may be substituted for a manual signature.
If the drug was prescribed by generic name, which of the following shall be noted on the face of a prescription?
I. The name of the manufacturer or distributor.
II. The national drug code number.
III. The trade name.
a. I only
b. II only
c. III only
d. I or II or III only
Answer:
If the drug was prescribed by generic name, which of the following shall be noted on the face of a prescription?
I. The name of the manufacturer or distributor.
II. The national drug code number.
III. The trade name.
a. I only
b. II only
c. III only
d. I or II or III only
Answer: I or II or III only, [Title 12 Alaska Administrative Code (AAC) Section 52.460(b)(5)].
If the drug was prescribed by generic name or if an equivalent drug product other than the one prescribed was dispensed, for the drug product actually dispensed, at least ONE of the following shall be noted on the face of a prescription:
(A). the name of the manufacturer or distributor;
(B). the national drug code number;
(C). the short name code;
(D). the trade name.
A prescription for Cymbalta can be filled by selecting:
a. Lidocaine
b. Tramadol
c. Duloxetine
d. Diclofenac
Answer:
A prescription for Cymbalta can be filled by selecting:
a. Lidocaine
b. Tramadol
c. Duloxetine
d. Diclofenac
Answer:(c) A prescription for Cymbalta can be filled by selecting Duloxetine. It is indicated for the treatment of depression.
Products that are not commercially available may be compounded for hospital or office use.
True or False
Products that are not commercially available may be compounded for hospital or office use.
True, [New Hampshire Statutes Chapter 318 Section 318-14-a(I)].
Products that are not commercially available may be compounded for hospital or office use but shall not be resold or dispensed.
Nonprescription items may be compounded upon order by a practitioner for sale as long as the labeling complies with RSA 318:47-a and the product is not a copy of, or similar to, prescription or nonprescription products.
All of the following may increase a patient's adherence to medication therapy EXCEPT:
a. By asking an open-ended question to a patient regarding drug therapy.
Answer:
All of the following may increase a patient's adherence to medication therapy EXCEPT:
a. By asking an open-ended question to a patient regarding drug therapy.Answer: (c). A pharmacist may increase a patient's adherence to medication:
1. By asking open-ended questions rather than close-ended question.
An open-ended question is designed to encourage a full, meaningful answer using the subject's own knowledge and/or feelings. It is the opposite of a closed-ended question, which encourages a short or single-word answer. Open-ended questions also tend to be more objective and less leading than closed-ended questions.
An example of open-ended question should be:
a. Tell me about your medication therapy. (open-ended question)
A closed-ended question is a question format that limits respondents with a list of answer choices from which they must choose to answer the question.
An example of close-ended question should be:
a. Are you taking your medication?
2. By addressing cost concerns. A pharmacist may suggest cheap generics or therapeutic alternatives, tablet splitting if appropriate, or any assistance program.
3. By linking doses with daily activities, smartphone apps or alarms, pillboxes, auto refills, etc.
4. By avoiding medical lingo. Ask patients to repeat back what you've told them.
According to Washington State Pharmacy Law, a preceptor may designate a licensed pharmacist to supervise the intern during the preceptor’s absence from the site; however the hours of experience gained while the certified preceptor is absent from the site shall not be counted toward fulfilling any internship requirement.
Answer: True or False
According to Washington State Pharmacy Law, a preceptor may designate a licensed pharmacist to supervise the intern during the preceptor’s absence from the site; however the hours of experience gained while the certified preceptor is absent from the site shall not be counted toward fulfilling any internship requirement.
True,[Washington Administrative Code WAC 246-858-040(2)].
According to Washington State Pharmacy Law, a preceptor may designate a licensed pharmacist to supervise the intern during the preceptor's absence from the site; however the hours of experience gained while the certified preceptor is absent from the site shall not be counted toward fulfilling any internship requirement.
The intern shall send notification to the board of pharmacy on or before the intern's first day of training.
Such notification shall consist of the date, the name of the pharmacy, and the name of the preceptor where the intern expects to begin his/her internship.
The board of pharmacy shall promptly notify the intern of the acceptability of the preceptor under whom the intern expects to gain experience. Internship credit will not be accepted until the preceptor has been certified.